| Primary |
| Asthma |
50.0% |
| Asthma Exercise Induced |
5.7% |
| Cardiac Disorder |
5.7% |
| Neoplasm Skin |
5.7% |
| Cough |
3.8% |
| Hypersensitivity |
3.8% |
| Intentional Overdose |
3.8% |
| Prophylaxis |
3.8% |
| Contraception |
1.9% |
| Hypertension |
1.9% |
| Hyposmia |
1.9% |
| Hypothyroidism |
1.9% |
| Multiple Chemical Sensitivity |
1.9% |
| Seasonal Allergy |
1.9% |
| Secretion Discharge |
1.9% |
| Cerebral Infarction |
0.9% |
| Gastrooesophageal Reflux Disease |
0.9% |
| Rhinitis |
0.9% |
| Rhinitis Allergic |
0.9% |
| Urticaria Pigmentosa |
0.9% |
|
| Drug Ineffective |
12.7% |
| No Adverse Event |
9.1% |
| Dysphonia |
7.3% |
| Hypersensitivity |
7.3% |
| Pneumonia |
7.3% |
| Throat Irritation |
7.3% |
| Atrial Fibrillation |
3.6% |
| Coeliac Disease |
3.6% |
| Hallucination |
3.6% |
| Headache |
3.6% |
| Heart Rate Increased |
3.6% |
| Insomnia |
3.6% |
| Lacrimation Increased |
3.6% |
| Malaise |
3.6% |
| Pruritus Generalised |
3.6% |
| Pyrexia |
3.6% |
| Tendon Rupture |
3.6% |
| Underdose |
3.6% |
| Vocal Cord Inflammation |
3.6% |
| Adverse Event |
1.8% |
|
| Secondary |
| Asthma |
21.1% |
| Hypertension |
17.8% |
| Cerebral Infarction |
15.8% |
| Cholelithiasis |
15.8% |
| Back Pain |
13.4% |
| Drug Use For Unknown Indication |
10.5% |
| Rhinitis Allergic |
3.2% |
| Arthralgia |
0.8% |
| Multiple Allergies |
0.4% |
| Nasopharyngitis |
0.4% |
| Product Used For Unknown Indication |
0.4% |
| Rhinitis |
0.4% |
|
| Tubulointerstitial Nephritis |
34.4% |
| Vasculitis |
15.6% |
| Anaphylactic Shock |
6.3% |
| Drug Hypersensitivity |
6.3% |
| Leukocytoclastic Vasculitis |
6.3% |
| Hypertension |
3.1% |
| Influenza |
3.1% |
| Medication Error |
3.1% |
| Nephritis Interstitial |
3.1% |
| Palpitations |
3.1% |
| Retinal Ischaemia |
3.1% |
| Sinus Congestion |
3.1% |
| Tremor |
3.1% |
| Visual Field Defect |
3.1% |
| White Blood Cell Count Increased |
3.1% |
|
| Concomitant |
| Asthma |
34.8% |
| Product Used For Unknown Indication |
8.7% |
| Bronchitis |
6.8% |
| Drug Use For Unknown Indication |
5.5% |
| Pneumonia |
5.4% |
| Otitis Media |
5.0% |
| Upper Respiratory Tract Inflammation |
4.6% |
| Rhinitis Allergic |
4.5% |
| Pain |
3.4% |
| Tonsillitis |
3.1% |
| Pyrexia |
2.3% |
| Conjunctivitis |
2.1% |
| Prophylaxis Against Dehydration |
2.0% |
| Pseudocroup |
2.0% |
| Hypertension |
1.9% |
| Pancreatic Neuroendocrine Tumour |
1.8% |
| Reflux Oesophagitis |
1.5% |
| Prophylaxis |
1.5% |
| Convulsion |
1.4% |
| Insomnia |
1.4% |
|
| Asthma |
11.2% |
| Tubulointerstitial Nephritis |
7.7% |
| Pneumonia |
7.0% |
| Acute Tonsillitis |
5.6% |
| Rhinitis |
5.6% |
| Sinusitis |
5.6% |
| Vomiting |
5.6% |
| Wheezing |
5.6% |
| Product Quality Issue |
4.9% |
| Subileus |
4.9% |
| Nausea |
4.2% |
| Pancreatic Disorder |
4.2% |
| Throat Irritation |
4.2% |
| Weight Decreased |
4.2% |
| Pneumothorax |
3.5% |
| Pyrexia |
3.5% |
| Urticaria |
3.5% |
| Vasculitis |
3.5% |
| Abnormal Behaviour |
2.8% |
| Interstitial Lung Disease |
2.8% |
|
